Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 775.75
BSDM's Cash to Debt is ranked higher than
84% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. BSDM: 775.75 )
BSDM' s 10-Year Cash to Debt Range
Min: 4.22   Max: No Debt
Current: 775.75

Equity to Asset 0.86
BSDM's Equity to Asset is ranked higher than
90% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. BSDM: 0.86 )
BSDM' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.97
Current: 0.86

0.26
0.97
Interest Coverage No Debt
BSDM's Interest Coverage is ranked higher than
93% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. BSDM: No Debt )
BSDM' s 10-Year Interest Coverage Range
Min: 16.98   Max: 9999.99
Current: No Debt

16.98
9999.99
F-Score: 3
Z-Score: -5.01
M-Score: -3.36
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -158.27
BSDM's Operating margin (%) is ranked higher than
51% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 5.53 vs. BSDM: -158.27 )
BSDM' s 10-Year Operating margin (%) Range
Min: -472.69   Max: 30.78
Current: -158.27

-472.69
30.78
Net-margin (%) -158.27
BSDM's Net-margin (%) is ranked higher than
50% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 4.05 vs. BSDM: -158.27 )
BSDM' s 10-Year Net-margin (%) Range
Min: -471.37   Max: 515.82
Current: -158.27

-471.37
515.82
ROE (%) -80.03
BSDM's ROE (%) is ranked lower than
51% of the 440 Companies
in the Global Medical Devices industry.

( Industry Median: 5.22 vs. BSDM: -80.03 )
BSDM' s 10-Year ROE (%) Range
Min: -171.85   Max: 1026.92
Current: -80.03

-171.85
1026.92
ROA (%) -67.85
BSDM's ROA (%) is ranked higher than
50% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.73 vs. BSDM: -67.85 )
BSDM' s 10-Year ROA (%) Range
Min: -66.3   Max: 126.56
Current: -67.85

-66.3
126.56
ROC (Joel Greenblatt) (%) -275.29
BSDM's ROC (Joel Greenblatt) (%) is ranked higher than
54% of the 470 Companies
in the Global Medical Devices industry.

( Industry Median: 9.36 vs. BSDM: -275.29 )
BSDM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -426.87   Max: 164.08
Current: -275.29

-426.87
164.08
Revenue Growth (3Y)(%) 19.70
BSDM's Revenue Growth (3Y)(%) is ranked higher than
93% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. BSDM: 19.70 )
BSDM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -35.6   Max: 55.4
Current: 19.7

-35.6
55.4
EBITDA Growth (3Y)(%) -6.70
BSDM's EBITDA Growth (3Y)(%) is ranked higher than
69% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. BSDM: -6.70 )
BSDM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -30.7   Max: 94.3
Current: -6.7

-30.7
94.3
EPS Growth (3Y)(%) -6.70
BSDM's EPS Growth (3Y)(%) is ranked higher than
70% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. BSDM: -6.70 )
BSDM' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 26
Current: -6.7

0
26
» BSDM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

BSDM Guru Trades in

BSDM Guru Trades in

BSDM Guru Trades in

Q3 2014

BSDM Guru Trades in Q3 2014

Jim Simons 82,100 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with BSDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.50
BSDM's P/B is ranked higher than
93% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 4.18 vs. BSDM: 1.50 )
BSDM' s 10-Year P/B Range
Min: 0.95   Max: 17.73
Current: 1.5

0.95
17.73
P/S 2.50
BSDM's P/S is ranked higher than
81% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. BSDM: 2.50 )
BSDM' s 10-Year P/S Range
Min: 1.5   Max: 87.88
Current: 2.5

1.5
87.88
EV-to-EBIT -0.31
BSDM's EV-to-EBIT is ranked higher than
67% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 74.50 vs. BSDM: -0.31 )
BSDM' s 10-Year EV-to-EBIT Range
Min: -71.1   Max: -0.3
Current: -0.31

-71.1
-0.3
Current Ratio 6.18
BSDM's Current Ratio is ranked higher than
89% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. BSDM: 6.18 )
BSDM' s 10-Year Current Ratio Range
Min: 1.29   Max: 40.45
Current: 6.18

1.29
40.45
Quick Ratio 4.56
BSDM's Quick Ratio is ranked higher than
87% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. BSDM: 4.56 )
BSDM' s 10-Year Quick Ratio Range
Min: 0.42   Max: 36.37
Current: 4.56

0.42
36.37
Days Inventory 318.32
BSDM's Days Inventory is ranked higher than
57% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 160.07 vs. BSDM: 318.32 )
BSDM' s 10-Year Days Inventory Range
Min: 239.32   Max: 578.66
Current: 318.32

239.32
578.66
Days Sales Outstanding 26.01
BSDM's Days Sales Outstanding is ranked higher than
98% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 79.24 vs. BSDM: 26.01 )
BSDM' s 10-Year Days Sales Outstanding Range
Min: 8.65   Max: 182.37
Current: 26.01

8.65
182.37

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.80
BSDM's Price/Net Cash is ranked higher than
99% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BSDM: 2.80 )
BSDM' s 10-Year Price/Net Cash Range
Min: 3.04   Max: 87.5
Current: 2.8

3.04
87.5
Price/Net Current Asset Value 2.10
BSDM's Price/Net Current Asset Value is ranked higher than
99% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BSDM: 2.10 )
BSDM' s 10-Year Price/Net Current Asset Value Range
Min: 2.5   Max: 256.2
Current: 2.1

2.5
256.2
Price/Tangible Book 1.50
BSDM's Price/Tangible Book is ranked higher than
96% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 7.44 vs. BSDM: 1.50 )
BSDM' s 10-Year Price/Tangible Book Range
Min: 1.82   Max: 42.7
Current: 1.5

1.82
42.7
Price/Median PS Value 0.10
BSDM's Price/Median PS Value is ranked higher than
100% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. BSDM: 0.10 )
BSDM' s 10-Year Price/Median PS Value Range
Min: 0.12   Max: 5.45
Current: 0.1

0.12
5.45
Earnings Yield (Greenblatt) -208.80
BSDM's Earnings Yield (Greenblatt) is ranked lower than
58% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. BSDM: -208.80 )
BSDM' s 10-Year Earnings Yield (Greenblatt) Range
Min: -208.8   Max: 0
Current: -208.8

-208.8
0

Analyst Estimate

Mar15
EPS($) -0.08
EPS without NRI($) -0.08

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:BZD.Germany,
BSD Medical Corp was originally incorporated under the laws of the State of Utah on March 17, 1978. On July 3, 1986, the Company was reincorporated in the State of Delaware The Company develops, manufactures, market and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. Its product line for cancer therapy has been created to offer hospitals and clinics a complete solution for thermal treatment of cancer using microwave/RF systems. Microwave ablation system is used to ablate (destroy) soft tissue with heat alone. Thermal ablation is used to destroy local tumors using a short intense focus of heat on a specific area, which is usually small, similar to surgical removal of the tumor. Its product line includes systems that have been strategically designed to offer a range of thermal treatment systems for the treatment of cancer, including both hyperthermia and ablation treatment systems. Current and future cancer treatment sites for its systems may include cancers of the prostate, breast, head, neck, bladder, cervix, colon/rectum, ovaries, esophagus, liver, kidney, brain, bone, stomach and lung. The BSD-500 comes in several versions, depending on the customer requirements. The BSD-2000 Hyperthermia System, or the BSD-2000, family of products includes the BSD-2000, the BSD-2000/3D and the BSD-2000/3D/MR. These systems non-invasively deliver localized therapeutic heating (hyperthermia) to solid tumors by applying radiofrequency (RF) energy to certain cancerous tumors, including those located deep within the body. These systems consist of four major subsystems: an RF power generator delivery subsystem; a proprietary, thermistor-based, thermometry subsystem; a computerized monitoring and control subsystem; and an applicator subsystem that includes an applicator and patient support system; as well as various accessories. As a further enhancement of the BSD-2000/3D, it has added to it the option of concurrent magnetic resonance imaging, or MRI, used for non-invasively monitoring the tissue temperatures during delivery of deep hyperthermia therapy. Its target customers include clinics, hospitals and institutions in which cancer is treated, located either in the United States or international markets. The company generally provides a 12-month warranty and record a liability for the warranty following installation on all cancer treatment systems and a 90-day limited warranty on individual components. Competitors in the thermal ablation market include RadioTherapeutics, a division of Boston Scientific Corporation, Covidien Ltd., Angiodynamics, Inc. and Microsulis Medical Ltd. The medical devices that it has developed and is developing are subject to extensive and rigorous regulation by numerous governmental authorities, principally by the FDA, and comparable foreign agencies.
» More Articles for BSDM

Headlines

Articles On GuruFocus.com
BSD Medical Corp. Reports Operating Results (10-Q) Jan 14 2011 
BSD Medical Corp. Reports Operating Results (10-K) Nov 29 2010 
BSD Medical Corp. Reports Operating Results (10-Q) Jan 14 2010 
BSD Medical Corp. Reports Operating Results (10-Q) Jul 10 2009 
BSD Medical Corp. Reports Operating Results (10-Q) Apr 09 2009 
BSD Medical Corp. Reports Operating Results for Fiscal Quarter Ended on 2008-11-30 Jan 10 2009 

More From Other Websites
BSD Medical Corporation Provides Progress Update on Strategic Plan Jan 29 2015
12:52 pm BSD Medical provides progress update on strategic plan; Submits non-binding term sheet for... Jan 29 2015
BSD Medical Corporation Provides Progress Update on Strategic Plan Jan 29 2015
BSD MEDICAL CORP Financials Jan 21 2015
10-Q for BSD Medical Corp. Jan 16 2015
BSD MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 15 2015
BSD Medical Corporation Reports First Quarter 2015 Financial Results Jan 15 2015
BSD Medical Corporation Reports First Quarter 2015 Financial Results Jan 15 2015
BSD MEDICAL CORP Files SEC form 10-Q, Quarterly Report Jan 14 2015
BSD Medical Corporation Outlines Strategy and Revenue Targets for Microwave Ablation Solutions Jan 12 2015
BSD Medical Corporation Outlines Strategy and Revenue Targets for Microwave Ablation Solutions Jan 12 2015
BSD MEDICAL CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jan 12 2015
BSD Medical Corporation Announces Investor & Analyst Conference Call Dec 29 2014
BSD Medical Corporation Announces Investor & Analyst Conference Call Dec 29 2014
10-K for BSD Medical Corp. Nov 15 2014
BSD MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2014
BSD MEDICAL CORP Files SEC form 10-K, Annual Report Nov 13 2014
BSD Medical Announces Fiscal Year 2014 Financial Results Nov 13 2014
BSD Medical Announces Fiscal Year 2014 Financial Results Nov 13 2014
BSD MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Nov 12 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK